Pharmacy reform must look at ‘bigger picture’
October 29, 2003MPs have criticised a report recommending opening up community pharmacy to greater competition, saying its value had been misunderstood.David Hinchcliffe, …
Generic threat to Lilly’s biggest seller
October 29, 2003A court challenge to Eli Lilly's patent on its number one drug Zyprexa could spell serious trouble for the company, …
AstraZeneca buoyed by Crestor clearance
October 29, 2003AstraZeneca's new statin drug has received unanimous approval by a key FDA panel, and now looks set to be launched …
CROs continue to extend global reach
October 29, 2003Contract research organisations from Europe and the US are continuing to expand their operations in order to meet the pharmaceutical …
Call for free price-setting across Europe
October 29, 2003Pharmaceutical companies should be allowed to set their own prices in all European Union countries in order to bring a …
GSK and Novartis settle over Augmentin
October 29, 2003GlaxoSmithKline has reached an agreement with Novartis in its court action over stolen trade secrets for its antibiotic Augmentin.Novartis will …
OGS withdraws CAT offer recommendation
October 29, 2003Oxford GlycoSciences has withdrawn its support of Cambridge Antibody Technology's £110 million all-share bid for the company, despite believing a …
Foundation hospitals survive Labour revolt
October 29, 2003Plans for foundation hospitals have been narrowly passed by the House of Commons despite a revolt by Labour MPs that …
Schering’s Angeliq approved in Europe
October 29, 2003Schering's new low dose HRT product Angeliq has gained mutual recognition in the European Union, with launches expected across the …
Pharma urged to reduce animal testing
October 29, 2003The pharmaceutical industry should test more drugs in humans at a pre-clinical stage to reduce numbers of primates used, a …
Blockbuster combination unveiled as Pfizer marches on
October 29, 2003Pfizer is to launch a new double-blockbuster cardiovascular product to help further its position as the Goliath of the pharmaceutical …
Profits continue to plummet at Schering-Plough
October 29, 2003Schering-Plough has issued its third earnings warning this year as it continues to suffer under an onslaught from generic competition.The …
Faster market access for generics in US
October 29, 2003Laws governing the entry of generic drugs on the US market are to be streamlined in an effort to cut …
AstraZeneca rises on Crestor hopes
October 29, 2003AstraZeneca made significant stock market gains following indications its new superstatin Crestor will receive a positive review from US regulatory …
Elan sues King Pharma over drug sales
October 29, 2003Elan, King Pharmaceuticals
Elan is taking legal action to force King Pharmaceuticals to buy two drugs it urgently needs to divest to help …
GSK gives way on Paxil patents
October 29, 2003New measures by the FDA to speed up patient access to generic medicines have claimed their first scalp after GlaxoSmithKline …
Latest content
FibroFind appoints Lee Borthwick as CEO
